Compare MBRX & STAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MBRX | STAI |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.5M | 24.6M |
| IPO Year | 2016 | N/A |
| Metric | MBRX | STAI |
|---|---|---|
| Price | $7.24 | $0.29 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $125.00 | N/A |
| AVG Volume (30 Days) | 105.9K | ★ 2.8M |
| Earning Date | 11-13-2025 | 09-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,249,524.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 139.30 |
| 52 Week Low | $6.01 | $0.17 |
| 52 Week High | $91.25 | $12.19 |
| Indicator | MBRX | STAI |
|---|---|---|
| Relative Strength Index (RSI) | 89.96 | 36.56 |
| Support Level | $0.26 | $0.17 |
| Resistance Level | $7.75 | $0.42 |
| Average True Range (ATR) | 0.29 | 0.05 |
| MACD | 0.83 | -0.01 |
| Stochastic Oscillator | 93.19 | 45.89 |
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.
ScanTech AI Systems Inc is developing and deploying security screening systems that protect travelers and other public members from criminals, terrorists, and other bad actors. It has developed a proprietary Computed Tomography scanning system that uses fixed-gantry technology to detect explosives, weapons, narcotics, and other contraband.